Dawn H. Mitchell

686 total citations
16 papers, 536 citations indexed

About

Dawn H. Mitchell is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Dawn H. Mitchell has authored 16 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Genetics and 3 papers in Oncology. Recurrent topics in Dawn H. Mitchell's work include Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (5 papers) and Glioma Diagnosis and Treatment (3 papers). Dawn H. Mitchell is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (5 papers) and Glioma Diagnosis and Treatment (3 papers). Dawn H. Mitchell collaborates with scholars based in United States and Switzerland. Dawn H. Mitchell's co-authors include Kevin O. Lillehei, Carol A. Kruse, C A Kruse, Bette K. Kleinschmidt‐DeMasters, Collins Dc, Donald Bellgrau, Helvise G. Morse, Wilbur A. Franklin, Marc Sakwa and Arlen R. Holter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Dawn H. Mitchell

15 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawn H. Mitchell United States	12	224	208	94	81	76	16	536
M Zavanone Italy	15	81 0.4×	51 0.2×	55 0.6×	131 1.6×	130 1.7×	33	582
N. T. CHEUNG United Kingdom	7	190 0.8×	121 0.6×	33 0.4×	105 1.3×	32 0.4×	10	597
Ingrid Arvidsson Sweden	14	110 0.5×	59 0.3×	130 1.4×	105 1.3×	175 2.3×	24	889
Xian Su China	12	153 0.7×	88 0.4×	45 0.5×	189 2.3×	35 0.5×	33	501
A.M. Graulet France	15	89 0.4×	177 0.9×	42 0.4×	396 4.9×	63 0.8×	23	737
Noriyoshi Sueyoshi Japan	14	82 0.4×	75 0.4×	46 0.5×	257 3.2×	364 4.8×	36	898
Sverker Eneström Sweden	12	116 0.5×	33 0.2×	28 0.3×	93 1.1×	45 0.6×	33	506
Anne‐Marie Jank Germany	4	116 0.5×	118 0.6×	183 1.9×	265 3.3×	89 1.2×	4	835
Nurbek Mambetsariev United States	12	106 0.5×	86 0.4×	27 0.3×	220 2.7×	96 1.3×	21	618
Olivera Mitrović Ajtić Serbia	12	96 0.4×	68 0.3×	150 1.6×	216 2.7×	75 1.0×	60	571

Countries citing papers authored by Dawn H. Mitchell

Since Specialization

Citations

This map shows the geographic impact of Dawn H. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn H. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn H. Mitchell more than expected).

Fields of papers citing papers by Dawn H. Mitchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn H. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn H. Mitchell. The network helps show where Dawn H. Mitchell may publish in the future.

Co-authorship network of co-authors of Dawn H. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn H. Mitchell. A scholar is included among the top collaborators of Dawn H. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn H. Mitchell. Dawn H. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Smith, Zachary, et al.. (2024). EE343 Cost-Effectiveness Analysis of Resmetirom for the Treatment of Adults With Noncirrhotic NASH and Moderate-to-Advanced Liver Fibrosis in the US: Integrating the Dual NASH Resolution and Fibrosis Improvement Endpoints. Value in Health. 27(12). S122–S122.

Sakwa, Marc, et al.. (2009). Coronary artery bypass grafting with a minimized cardiopulmonary bypass circuit: A prospective, randomized trial. Journal of Thoracic and Cardiovascular Surgery. 137(2). 481–485. 34 indexed citations

Mitchell, Dawn H., et al.. (1996). Replacement Therapy: Arginine Vasopressin (AVP), Growth Hormone (GH), Cortisol, Thyroxine, Testosterone and Estrogen. Journal of Neuroscience Nursing. 28(3). 140–154. 3 indexed citations

Kruse, Carol A., Dawn H. Mitchell, Bette K. Kleinschmidt‐DeMasters, et al.. (1993). Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcoma. Journal of Neuro-Oncology. 15(2). 97–112. 24 indexed citations

Kleinschmidt‐DeMasters, Bette K., et al.. (1993). Alveolar soft part sarcoma: An unusually long interval between presentation and brain metastasis. Human Pathology. 24(9). 1030–1034. 34 indexed citations

Mulvin, D., Randy B. Howard, Dawn H. Mitchell, et al.. (1992). Secondary Screening System for Preclinical Testing of Human Lung Cancer Therapies. JNCI Journal of the National Cancer Institute. 84(1). 31–37. 4 indexed citations

Kruse, Carol A., Dawn H. Mitchell, Bette K. Kleinschmidt‐DeMasters, et al.. (1992). Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses. In Vitro Cellular & Developmental Biology - Animal. 28(9-10). 609–614. 55 indexed citations

Lillehei, Kevin O., et al.. (1991). Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy. Neurosurgery. 28(1). 16–16. 90 indexed citations

Mitchell, Dawn H., et al.. (1991). Prevention of thromboembolic disease following total knee arthroplasty. Epidural versus general anesthesia.. PubMed. 109–12. 30 indexed citations

10.

Mitchell, Dawn H., Stephen J. Withrow, Michael R. Johnston, & Carol A. Kruse. (1991). Cytotoxicity against autologous, allogeneic, and xenogeneic tumor targets by human recombinant interleukin-2-activated lymphocytes from healthy dogs and dogs with lung tumors. American Journal of Veterinary Research. 52(7). 1132–1136. 14 indexed citations

11.

Lillehei, Kevin O., et al.. (1991). Long-Term Follow-up of Patients with Recurrent Malignant Gliomas Treated with Adjuvant Adoptive Immunotherapy. Neurosurgery. 28(1). 16–23. 78 indexed citations

12.

Mitchell, Dawn H., et al.. (1990). Bioactivity of electric field-pulsed human recombinant interleukin-2 and its encapsulation into erythrocyte carriers.. PubMed. 12(3). 264–75. 18 indexed citations

13.

Kruse, C A, Kevin O. Lillehei, Dawn H. Mitchell, Bette K. Kleinschmidt‐DeMasters, & Donald Bellgrau. (1990). Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.. Proceedings of the National Academy of Sciences. 87(24). 9577–9581. 37 indexed citations

14.

Kruse, Carol A., et al.. (1989). Interleukin-2—activated lymphocytes from brain tumor patients. A comparison of two preparations generatedin vitro. Cancer. 64(8). 1629–1637. 23 indexed citations

15.

Pizer, Lewis I., et al.. (1987). A mammalian cell line designed to test the mutagenic activity of anti‐herpes nucleosides. International Journal of Cancer. 40(1). 114–121. 2 indexed citations

16.

Mitchell, Dawn H., et al.. (1984). The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics.. PubMed. 63(4). 452–6. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact